Ahmed Hamdy

[Ahmed Hamdy @theHamdy64]

@DrLizBrem Btk works both Ibrutinib and acala have been tested

https://t.co/Kk3S34ADgD

Ohio state veterinary school

https://t.co/1uasVLVS2c

[Ahmed Hamdy @theHamdy64]

@graham74GC @RDMOxford @shapiro_susie Congratulations!! Very well deserved

[Ahmed Hamdy @theHamdy64]

@graham74GC Best wishes for a speedy recovery

[Alexander Wolf @BaskinEng_Dean]

Researchers from @UCSCGenomics have designed an ingenious genetic mapping tool that effectively captures the diversity of the human genome, removing bias from human genotyping and allowing for improved analysis of genetic variation. #BaskinEngineering https://t.co/61WnwO0xaM

[Ahmed Hamdy @theHamdy64]

@AshAlizadeh Deepest condolences what a loss

[Toby Eyre @tobyeyre82]

How to best manage covBTKi+BCL2i exposed R/R #CLL pts?
Check out @MCThompsonMD et al
Largest international series
n=125
ORR+PFS
CAR T 85.7% mPFS 4m
alloSCT 76.5% mPFS 11m
ncBTKi 75.0% mPFS NR
PI3Ki 40.9% mPFS 5m
CIT 31.8% mPFS 3m

Non-cov BTKi, CART promising approaches #ASH21

[Alexander Wolf @BaskinEng_Dean]

UCSC's annual Giving Day is here! Join me today to invest in #BaskinEngineering student organizations and faculty projects. Your gift will support inclusive student success and world-class faculty research. Together we can make a difference: https://t.co/NstOQm450P
#Give2UCSC

[UC Santa Cruz Genomics Institute @ucscgenomics]

IT'S ON! Join us on Giving Day, a 24-hour fundraiser starting NOW. We’re helping raise $ for the Research Mentoring Internship Program (RMI) to expand our support for diversity and excellence in STEM! Visit https://t.co/SRyG2yUS6S to donate until 11:59 PM today!

#give2UCSC

[Toby Eyre @tobyeyre82]

Pleased to share #acalabrutinib in #Richters transformation in @TheLancetHaem

Difficult to Rx population
ORR 40%
Some durable responses seen
Well tolerated
Targeting BTK valuable
Combination + improved biomarker-driver approaches needed! #lymsm #CLL

https://t.co/zWdS0he1vo

[Jonathan Friedberg @DrJFriedberg]

"Simply the Best" Treatment for CLL. Nice editorial by my @SWOG colleague @DebbieMStephens in #JCO @ASCO_pubs
https://t.co/AJuj3h39wc

[Ahmed Hamdy @theHamdy64]

@BaskinEng Congratulations Todd

[Ahmed Hamdy @theHamdy64]

@RebeccaH2030 Ouch!!!

[Ahmed Hamdy @theHamdy64]

@DrMDavids Matt which BTk was used in this trial? Wonder if there would be differences between Ibrutinib and calquence?

[Ahmed Hamdy @theHamdy64]

@OncoAlert @myESMO @ASCO @CancerCareMASCC @SIOGorg @cancernurseEU @VJOncology @ecancer @sloan_kettering @AstraZeneca @ESOncology Sad news may he Rest In Peace

[Nasdaq Exchange @NasdaqExchange]

Welcome to the @Nasdaq family, Vincera Pharma, Inc.! 🎉

Vincera Pharma, Inc. is a clinical-stage biopharmaceutical company focused on leveraging its extensive development and oncology expertise to advance new therapies.

#NasdaqListed: $VINC

[Ahmed Hamdy @theHamdy64]

@gilles_salles Congratulations looking forward to working with you in developing therapies for cancer Patients

[Baskin Engineering at UCSC @BaskinEng]

Ahmed Hamdy (@theHamdy64), a member of the Baskin Engineering Dean's Council, has contributed to a paper on a new possible therapeutic strategy in severe
COVID-19 cases 👏🏼 👏🏽 👏🏿https://t.co/7dVDMPipSt

[Mark Roschewski @RoschewskiMD]

Inhibition of Bruton tyrosine kinase in patients with severe COVID-19 https://t.co/pksLdAbO50